Energy News / Shareholders Foundation, Inc.

NASDAQ:CGIX Shareholder Notice: Deadline on June 4th in Lawsuit Against Cancer Genetics, Inc

Via: ReleaseWire

Updated 11:45 AM CDT, Wed, May 30,2018

A Deadline is coming up on June 4, 2018 in the lawsuit for investors in Cancer Genetics, Inc. (NASDAQ: CGIX) and NASDAQ: CGIX stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 05/30/2018 -- A deadline is coming up on June 4, 2018 in the lawsuit filed for certain investors in NASDAQ: CGIX shares over alleged securities laws violations by Cancer Genetics, Inc. .

Investors who purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX have certain options and there are strict and short deadlines running. Deadline: June 4, 2018. NASDAQ: CGIX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Cancer Genetics, Inc. (NASDAQ: CGIX) common shares between March 23, 2017 and April 2, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 23, 2017 and April 2, 2018, the defendants made false and/or misleading statements and/or failed to disclose that Cancer Genetics had ineffective disclosure controls and internal controls over financial reporting, and that as a result, Defendants' statements about the Company's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.

Those who purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqcgix-shareholder-notice-deadline-on-june-4th-in-lawsuit-against-cancer-genetics-inc-986947.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com